Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes-Reply.
作者信息
Wang Feng, Zhao Qi, Xu Rui-Hua
机构信息
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
出版信息
JAMA Oncol. 2020 Apr 1;6(4):590. doi: 10.1001/jamaoncol.2020.0068.
PMID:32134432
Abstract
摘要
Zotero 插件